Tel Aviv / Zurich, May 29, 2018 – SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN) (“SHL”), a leading provider and developer of advanced personal telemedicine solutions, announced today that it has generated an income of EUR 6.2 million from cost savings it delivered under a Chronic Disease Management Services contract in Germany, relating to the year 2016. This income will be recognized as revenue in the company’s 2018 financial statements.
For more information Click here 
				
				SHL to record additional income in 2018 from contract in Germany
																			
										Facebook									
																	
													
																			
										Twitter									
																	
													
																			
										LinkedIn									
																	
													
																			
										Pinterest									
																	
													